US based medical technology company, Intelligent Bio Solutions Inc (INBS), has received guidance from the US Food and Drug Administration (FDA) on regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge.

The medical technology company specialises in smart non-invasive testing solutions, and with its Intelligent Fingerprinting Drug Screening Cartridge they can offer rapid testing of certain drugs.

To date, the FDA have provisionally classified the cartridge under 21 CFR 862.3650 as an Opiate Test System, a Class II device requiring a pre-market notification 510(k) submission and FDA clearance before being put on the market. This initial assessment opens the door for INBS to expand into the US, which is inline with its current growth strategy.

Following the guidance from the FDA INBS plans to submit a 510(k)-pre-market notification for its proprietary Intelligent Fingerprinting Drug Screening Cartridge.

Harry Simeonidis, President and CEO of Intelligent Bio Solutions, expressed his satisfaction with the FDA’s preliminary assessment, stating, “We are pleased to receive the FDA’s provisional classification for our Intelligent Fingerprinting Drug Screening Cartridge, which represents a significant milestone in our expansion into the US market. Our intelligent drug screening technology, with its fast collection time and portability, has the potential to redefine workplace testing by establishing a new standard for drug testing procedures that prioritize employee dignity while enhancing operational efficiency for employers.”

The Intelligent Fingerprinting Drug Screening System detects the presence of specific drugs and their metabolites through fingerprint sweat analysis. Using a small, tamper-evident drug screening cartridge the device can collect ten fingerprint sweat samples in under a minute.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

These tamper-proof cartridges are designed to simultaneously screen for multiple drug groups, including opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine.

This non-invasive and rapid drug screening solution guarantees the employees well-being while maintaining workplace safety, while complying with health and safety policies. The technology has already gained positive feedback from INBS’s customer base of over 350 clients in multiple countries.

At present the Intelligent Fingerprinting Drug Screening device is being used in the UK. In 2022 Goldstar Transport, a container haulier firm, purchased six Intelligent Fingerprinting portable readers and has been conducting random drug tests every month. Elsewhere in the UK glass manufacturer, Glass Systems, implemented the use of device for drug screening its employees.